VANCOUVER, BC--(Marketwired - January 11, 2018) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (NRXCF) (1N9.F), the innovator and pioneer behind neuenergy®, is pleased to announce a one-year sponsorship deal with Canadian and International tennis star Genie Bouchard, from Montreal, Quebec.
NeutriSci is committed to encouraging active, healthy living and adds Bouchard to a growing list of amateur and professional athletes and ambassadors that represent neuenergy® globally. "Genie brings a passion for sport and healthy living. She is not only an amazingly talented tennis player but her down to earth attitude makes her the perfect representative; both men and women can relate to her," said Glen Rehman, CEO of NeutriSci. "Her competitive nature and public profile embodies happiness, active and healthy living; and because of this, she is truly an inspiration to Canadians. We are proud to partner with such a strong Canadian athlete."
Bouchard has quickly made a name for herself due to her tremendous talent and drive. Genie has accumulated impressive accolades including being named the 2013 Women's Tennis Association Newcomer of the Year and the 2013 Canadian Female Athlete of the Year. Genie's historic 2014 season was highlighted by a WTA Top 5 debut, after reaching the semifinals of both the Australian Open and French Open, followed by a Wimbledon final appearance, making her the first Canadian, male or female, to reach a Grand Slam final.
As part of the agreement, Bouchard will be integrated into key marketing efforts for the neuenergy® brand -- including advertising, retail activation, experiential events and more.
"I am excited to partner with one of Canada's up and coming brands," said Genie Bouchard. "Neuenergy represents a healthy alternative to traditional energy products."
On Behalf of the Board of Directors of
NEUTRISCI INTERNATIONAL INC.
NeutriSci International Inc.
About NeutriSci International Inc.
NeutriSci specializes in the innovation, production, and formulation of nutraceutical products. Established in 2009, NeutriSci's is building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy®, the Company's natural energy and focus supplement that has at its core, the beneficial effects of blueberries.
Neuenergy® contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine, and is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products. To find out more about neuenergy®, please visit www.getneuenergy.com.
For more information, please visit: www.neutrisci.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.
Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure, or prevent any disease.